Why a Covaxin Controversy in Bhopal is worrying trial participants, activists and experts

Bharat Biotech’s Covaxin is one of the two Indian vaccines being administered to healthcare workers as India embarks on the world’s largest inoculation drive. Health experts have expressed concerns as hundreds of Bhopal Gas Tragedy survivors say they had been enrolled in the clinical trial for Covaxin without their informed consent. One of the trial participants, Deepak Marabi, passed away on December 21, 2020.  Join us on this episode of The Suno India Show, as our reporter Suryatapa Mukherjee explores the alleged violation of the rights of this vulnerable group as well as the alleged misconduct of the clinical trial. These participants say they weren’t adequately monitored and their adverse reactions to the vaccine weren’t properly recorded.  She speaks to Rachna Dhingra, the activist with Bhopal Group of Information and Action who first tweeted about these ethical and legal violations. You will also hear from some of the trial participants, and Anant Bhan, who works in the field of bioethics and global health.  Vice Chancellor Dr Rajesh Kapur’s statement Bharat Biotech’s statement National Ethical Guidelines National Guidelines for Covid-19 Pandemic Being an editorially independent platform, we rely on you to help us bring in untold stories that have the potential for social change. Do consider supporting us! See sunoindia.in/privacy-policy for privacy information.

2356 232

Suggested Podcasts

Fran Excell: Success Mindset Mentor For Business Owners.

Joann Filomena, Life Coach School Certified Life Coach, Widow Coach, and Weight Loss Coach

Jeremiah Roberts, Andrew Soncrant

Audacious Machine Creative

Bloody FM

Just Press Playhouse

InsideEVs - Electric Vehicle News